Clinical Trial Update: Pilot Study Sorafenib as Bridge to Orthotopic Liver Transplantation (OLT) [EARLY_Phase 1]

View source ↗

Summary

Pilot early-phase trial evaluating sorafenib as a bridge to orthotopic liver transplantation for hepatocellular carcinoma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Nexavar (Sorafenib)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Carcinoma, Hepatocellular | EARLY_Phase 1 | Status: TERMINATED